Cargando…
MO33-1 Trends in chemotherapy at our hospital and department under the COVID-19 pandemic
Autores principales: | Kageyama, Akihiko, Makino, Shinichiro, Ohigashi, An, Tamura, Taichi, Morita, Yuka, Nakamura, Shohei, Yagi, Yu, Kanemasa, Yusuke, Shimoyama, Tatsu, Omuro, Yasushi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Society for Medical Oncology. Published by Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8311563/ http://dx.doi.org/10.1016/j.annonc.2021.05.647 |
Ejemplares similares
-
Impact of pegfilgrastim approval on relative dose intensity and outcomes of R-CHOP for diffuse large B-cell lymphoma
por: Morita, Yuka, et al.
Publicado: (2022) -
Synchronous multiple primary tumors in patients with malignant lymphoma: a retrospective study
por: Yagi, Yu, et al.
Publicado: (2022) -
Multimodal Treatment of Extragonadal Choriocarcinoma with Multiple Brain and Lung Metastases: A Case Report
por: Uematsu, Mao, et al.
Publicado: (2019) -
Chimeric antigen receptor T-cell therapy following autologous transplantation for secondary central nervous system lymphoma: A case report
por: Yagi, Yu, et al.
Publicado: (2021) -
P1153: UTILITY OF THE FRAILTY SCORE FOR PREDICTING PROGNOSIS AND INDIVIDUALIZING TREATMENT INTENSITY IN ELDERLY PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA
por: Yagi, Yu, et al.
Publicado: (2023)